Cited by — Early mepolizumab initiation during remission induction is associated with lower organ damage burden in EGPA: a multicentre cohort study | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Early mepolizumab initiation during remission induction is associated with lower organ damage burden in EGPA: a multicentre cohort study.
No admitted local citation edges point to this work yet.
